This is a win for cancer patients and their families. The final deal protects access to quality, affordable health insurance for millions covered by Medicaid without including ineffective work requirements. It also avoids drastic cuts to spending and limits caps that could have substantially affected federal funding for cancer research.
House Bill 1301 aimed to fund a multiethnic cohort study conducted by the University of Hawaii Cancer Center to understand the different factors contributing to higher incidence and mortality rates in certain cancers among certain groups in Hawaii.
Victory in the fight against cancer requires bold new public policies that promote cancer prevention, early detection of cancer, expanded access to quality, affordable health care. Lawmakers make many decisions that impact the lives of Virginians touched by cancer and their leadership is vital to defeating this disease. In 2023,
Today, the U.S. House of Representatives, in a 217-215 vote, passed the Limit, Save, Grow Act, advancing provisions that would greatly restrict access to affordable care and risk progress in the fight against cancer.
Today, the American Cancer Society Cancer Action Network (ACS CAN) sent a letter to Speaker Kevin McCarthy and House Democratic Leader Hakeem Jeffries detailing concerns on provisions in the Limit, Save and Grow Act that would restrict access to affordable health care and risk progress in cancer research.
This morning, House Speaker Kevin McCarthy proposed concepts to address the debt limit that would jeopardize Americans’ access to meaningful, affordable health care by implementing work requirements for the Medicaid health insurance program and threaten federally-funded cancer research by shrinking discretionary spending.
The American Cancer Society Cancer Action Network (ACS CAN) today announced the launch of a prospective study of a new tool that would automatically identify relevant clinical trials through one-button clinical trial matching integration within electronic health records (EHRs).